Aytu Biopharma (AYTU) Non Operating Investment Income (2016 - 2017)
Aytu Biopharma (AYTU) reported Non Operating Investment Income of -$292455.0 for Q2 2017, little changed quarter-over-quarter from -$292455.0 in Q1 2017.
Aytu Biopharma (AYTU) Non Operating Investment Income (2016 - 2017) Analysis & Trends
Aytu Biopharma (AYTU) has 2 years of Non Operating Investment Income data on file, last reported at -$292455.0 in Q2 2017.
- Non Operating Investment Income for Q2 2017 came in at -$292455.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2017 was -$353974.0 (changed N/A YoY), and the FY2017 annual result was -$61519.0, up 93.67% from the prior year.
- Non Operating Investment Income steadied at -$292455.0 in Q2 2017 per AYTU's latest filing, from -$292455.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $728100.0 in Q3 2016 and troughed at -$497164.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Aytu Biopharma | 23.76 Mn | -2.96 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -292,455.00 |
| Jun 30, 2017 | -292,455.00 |
| Mar 31, 2017 | -292,455.00 |
| Mar 31, 2017 | -292,455.00 |
| Dec 31, 2016 | -497,164.00 |
| Dec 31, 2016 | -497,164.00 |
| Sep 30, 2016 | 728,100.00 |
| Sep 30, 2016 | 728,100.00 |